ABC | Volume 114, Nº2, February 2020

Update Update of the Brazilian Guideline on Nuclear Cardiology – 2020 Arq Bras Cardiol. 2020; 114(2):325-429 SPECT in patients with known coronary artery disease. J Nucl Cardiol. 2013;20(5):748-54. 99. Navare SM, Mather J, Shaw LJ, Fowler MS, Heller GV. Comparison of risk stratificationwith pharmacologic and exercise stress myocardial perfusion imaging: A meta-analysis. J Nucl Cardiol 2004;11(5):551-6. 100. Slim HB, Nair SU, Arora S, Heller GV. Does location matter? Prognostic value of single-photon emission computed tomography myocardial perfusion imaging by vascular territory. J Nucl Cardiol. 2012;19(3):458-64. 101. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, et al; AmericanCollege of Cardiology/AmericanHeart Association/American Society for Nuclear Cardiology. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). Circulation. 2003;108(11):1404-18. 102. Shaw LJ, Iskandrian AE. Prognostic value of stress gated SPECT in patients with known or suspected coronary artery disease. J Nucl Cardiol. 2004;11(2):171-85. 103. Shaw LJ, BermanDS, Blumenthal RS, Budoff MJ, Faber TL, Goraya T, et al. Clinical imaging for prevention: Directed strategies for improved detection of presymptomatic patients with undetected atherosclerosis-Part I: Clinical imaging for prevention. J Nucl Cardiol 2008;15(1): e6-19.Errata em: J Nucl Cardiol. 2008;15(4):609. 104. Ross R, Blair SN, Arena R, Church TS, Després JP, Franklin BA, et al; American Heart Association Physical Activity Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council on Cardiovascular and Stroke Nursing; Council on Functional Genomics and Translational Biology; Stroke Council. Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: a case for fitness as a clinical vital sign: a scientific statement from the American Heart Association. Circulation. 2016;134(24):e653-99. 105. Forman DE, Arena R, Boxer R, Dolansky MA, Eng JJ, Fleg JL, et al; American Heart Association Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Quality of Care and Outcomes Research; and Stroke Council. Prioritizing functional capacity as a principal end point for therapies oriented to older adults with CVAS disease: A scientific statement for healthcare professionals from the American Heart Association. Circulation. 2017;135:e894-e918. 106. Fletcher GF, Ades PA, Kligfield P, Arena R, Balady GJ, Bittner VA, et al; American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee of the Council on Clinical Cardiology, Council on Nutrition, Physical Activity and Metabolism, Council on Cardiovascular and Stroke Nursing, and Council on Epidemiology and Prevention. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation. 2013; 128(8):873-934. 107. Cremer P, Hachamovitch R, Tamarappoo B. Clinical decision making with myocardial perfusion imaging in patients with known or suspected coronary artery disease. Semin Nucl Med. 2014; 44(4):320-9. 108. ISCHEMIA Trial Research Group, Maron DJ, Hochman JS, O'Brien SM, Reynolds HR, BodenWE et al. International Study of ComparativeHealth Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design. AmHeart J. 2018 Jul; 201:124-35. 109. MoroiM,YamashinaA,TsukamotoK,NishimuraT; J-ACCESS Investigators. Coronary revascularization does not decrease cardiac events in patients with stable ischemic heart disease but might do in those who showed moderate to severe ischemia. Int J Cardiol. 2012;158(2):246-52. 110. Hachamovitch R, BermanDS, Kiat H, Cohen I, Cabico JA, Friedman J, et al: Exercisemyocardial perfusion SPECT in patients without known coronary artery disease: Incremental prognostic value and use in risk stratification. Circulation. 1996;93(5):905-14. 111. Xie JX, Winchester DE, Phillips LM, Hachamovitch R, Berman DS, Blankstein R, et al. The elusive role of myocardial perfusion imaging in stable ischemic heart disease: Is ISCHEMIA the answer? J Nucl Cardiol. 2017;24(5):1610 -8. 112. Gada H, Kirtane AJ, Kereiakes DJ, Bangalore S, Moses JW, Généreux P, et al. Meta-analysis of trials on mortality after percutaneous coronary intervention compared with medical therapy in patients with stable coronary heart disease and objective evidence of myocardial ischemia. Am J Cardiol. 2015;115(9):1194-9. 113. De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA, Piroth Z, et al; FAME 2 Trial Investigators. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012;367(11):991-1001. 114. Petraco R, van de Hoef TP, Nijjer S, Sen S, van Lavieren MA, Foale RA, et al. Baseline instantaneous wave-free ratio as a pressure-only estimation of underlying coronary flow reserve: results of the JUSTIFY-CFR Study (Joined Coronary Pressure and Flow Analysis to Determine Diagnostic CharacteristicsofBasalandHyperemicIndicesofFunctionalLesionSeverity- Coronary Flow Reserve). Circ Cardiovasc Interv. 2014;7(4):492-502. 115. Feher A, Sinusas AJ. Quantitative Assessment of Coronary Microvascular Function: Dynamic Single-Photon Emission Computed Tomography, Positron Emission Tomography, Ultrasound, Computed Tomography, and Magnetic Resonance Imaging. Circ Cardiovasc Imaging. 2017;10(8):e006427 116. BermanDS, GermanoG. Clinical Applications Of Nuclear Cardiology. In: BermanDS, GermanoG. Clinical Gated Cardiac SPECT. NewYork: Futura Publishing Company. 1999; p.3-10. 117. Meneghelo RS, Araújo CGS, Stein R, Mastrocolla LE, Albuquerque PF, Serra SM, et al. Sociedade Brasileira de Cardiologia. III Diretrizes da Sociedade Brasileira de Cardiologia sobre Teste Ergométrico. Arq Bras Cardiol. 2010;95(5 Suppl 1):1-26. 118. Diamond GA, Forrester JS. Analysis probability as an aid in the clinical diagnosis of coronary artery disease. NEngl J Med. 1979;300(24):1350-8. 119. Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, et al; American College of Cardiology; American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina).ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J AmColl Cardiol. 2003;41(1):159-68. 120. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al; ESC Scientific Document Group. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention &Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315-81. 121. Nicolau JC, Chalela WA, Meneghetti JC, Ximenes AA, de Almeida CA ,Vítola JV, et al. Primeira Diretriz da Sociedade Brasileira de Cardiologia sobre Cardiologia Nuclear. Arq Bras Cardiol. 2002;78( Suppl 3):1-42. 122. Gupta NC, Esterbrooks DJ, Hilleman DE, Mohiuddin SM. Comparison of adenosine and exercise thallium -201 single-photon emission computed tomography (SPECT) myocardial perfusion imaging. The GE SPECT Multicenter Adenosine Study Group. J Am Coll Cardiol.1992;19(2):248-57. 123. DePuey EG, Corbett JR, Friedman JD, Goldstein RA, HenzlovaMJ, Hansen CL, et al. Imaging guidelines for nuclear cardiology procedures. J Nucl Cardiol. 2006;13(6): e21-171. 124. ThompsonRC,PatilH,ThompsonEC,ThomasGS,Al-AmoodiM,Kennedy KF, et al. Regadenoson pharmacologic stress for myocardial perfusion imaging: A three-way comparison between regadenoson administered at peak exercise, during walk recovery, or no-exercise. J Nucl Cardiol. 2013;20(2):214-21. 415